GoodRx Holdings (GDRX) Total Current Liabilities (2019 - 2026)

GoodRx Holdings has reported Total Current Liabilities for 8 years, with the latest figure at $859.2 million in Q1 2026.

• Quarterly Total Current Liabilities rose 731.08% year-over-year to $859.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $859.2 million (up 731.08% YoY) and the FY2025 annual result came in at $246.0 million, up 98.54% from the prior year.
• Total Current Liabilities improved to $859.2 million in Q1 2026 per GDRX's latest filing, from $246.0 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $859.2 million in Q1 2026 and troughed at $59.4 million in Q1 2022.
• A 5-year average of $157.1 million and a median of $114.4 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities slipped 11.28% in 2025, then surged 731.08% in 2026.
• Over 5 years, Total Current Liabilities stood at $76.3 million in 2022, then soared by 60.59% to $122.6 million in 2023, then rose by 1.1% to $123.9 million in 2024, then surged by 98.54% to $246.0 million in 2025, then surged by 249.26% to $859.2 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $859.2 million, $246.0 million, and $181.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.